TP53 and breast cancer: The secosterols bind to the p53 protein and induce it to misfold and lose the ability to bind to a consensus DNA sequence, signifying that they may contribute to cancers where wild-type inactivation of p53 occurs, such as breast cancer, colon cancer, colon adenoma, and neuroblastoma [146].